GlaxoSmithKline Pharmaceuticals Limited – NSE:GLAXO.NS

One share of GlaxoSmithKline Pharmaceuticals Limited stock can currently be purchased for approximately $1,737.15.

Unfortunately, GlaxoSmithKline Pharmaceuticals Limited's (GLAXO.NS) next earnings date is currently unknown.

Yes, GlaxoSmithKline Pharmaceuticals Limited pays dividends and its trailing 12-month yield is 1.93% with 0% payout ratio. The last GlaxoSmithKline Pharmaceuticals Limited stock dividend of $0 was paid on 11 Sep 2025.

GlaxoSmithKline Pharmaceuticals Limited has a market capitalization of 386.71B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5.36% to 34.54B US dollars.

GlaxoSmithKline Pharmaceuticals Limited is traded on the NSE under the ticker symbol "GLAXO.NS".

Company operates in the Healthcare sector and Drug Manufacturers - General industry.

Shares of GlaxoSmithKline Pharmaceuticals Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

GlaxoSmithKline Pharmaceuticals Limited's management team includes the following people:

• Mr. Raju Krishnaswamy Executive Director of Technical & Regional Supply Chain Head of South Asia(age: 59, pay: $51,800,000)
• Ms. Puja Thakur South Asia Fin. Director, Chief Financial Officer & Whole-Time Director(age: 49, pay: $32,760,000)

As Jul 2024, GlaxoSmithKline Pharmaceuticals Limited employs 3,211 workers, which is 13% less then previous month and 13% less then previous quarter.

GlaxoSmithKline Pharmaceuticals Limited is publicly traded company for more then 23 years since IPO on 1 Jul 2002.

The official website for GlaxoSmithKline Pharmaceuticals Limited is india-pharma.gsk.com.

GlaxoSmithKline Pharmaceuticals Limited can be reached via phone at +91 22 2495 9595.